Chiropractors in Virden, IL Accepting Medicare
2 Chiropractors found. Showing 1 - 2
 Austin Family Chiropractice, Inc. Chiropractor Medicare: Medicare Enrolled Practice Location: 157 N Springfield St, Virden, IL 62690 Phone: 217-965-3100 Fax: 845-875-0531 |
 Dr. Todd W. Austin, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 157 N Springfield St, Virden, IL 62690 Phone: 217-965-3100 Fax: 845-875-0531 |
News Archive
Teen births cost U.S. Government $9.1 billion in 2004
The U.S. government in 2004 incurred at least $9.1 billion in costs related to teen births, despite significant decreases in teen pregnancy and birth rates since the early 1990s, according to a report released on Monday by the National Campaign To Prevent Teen Pregnancy, USA Today reports (Koch [1], USA Today, 10/30).
Cardiovascular health similarities between chimpanzees and humans found
Doctors like to remind patients not to monkey around with their health, suggesting that a good diet and regular exercise improve longevity.
Could Ivermectin be an effective antiviral against SARS-CoV-2?
A double-blind, randomized, placebo-controlled clinical trial has recently demonstrated that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate of COVID-19 patients.
Scientists identify genetic basis for prostate cancer susceptibility in non-European population
A genome-wide study on Japanese subjects has identified 5 new genetic variations associated with prostate cancer and revealed differences and similarities between Europeans and Asians in susceptibility to the disease. Reported in Nature Genetics, the findings offer a first-ever glimpse of the genetic basis for prostate cancer susceptibility in a non-European population.
Nanoparticle carriers successfully deliver therapeutic doses of cancer drug
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach. They developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.
› Verified 2 days ago